EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Real-World Utility of GWAS-Based Diabetes Mellitus Panel Testing

In Hwa Jeong iD, Kyung-Won Hong iD, Ja-Eun Choi iD, Bo-Kyung Shine iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms27010275 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von In Hwa Jeong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Dong-A University College of Medicine, Dong-A University Hospital, Busan 49201, Republic of Korea. Hauptthemen laut MEDLINE: Genome-Wide Association Study, Diabetes Mellitus, Type 2. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study evaluated the clinical utility of a polygenic risk score (PRS)-based multigene panel test for predicting diabetes mellitus (DM) in a healthy population. A total of 302 individuals underwent genetic testing using the HelloGene™ DM panel, which includes four DM-related single nucleotide polymorphisms (CDKAL1, HHEX, KCNQ1, and TCF7L2). PRS values were calculated using an algorithm developed from the Korean Genome and Epidemiology Study (KoGES; n = 39,605), and participants were classified into four genetic risk groups (low, moderate, high, and very high). Fasting blood glucose, glycated hemoglobin (HbA1c), and body mass index were assessed at baseline and after at least three years of follow-up, and lifestyle factors including smoking, alcohol consumption, and exercise status were recorded. No significant differences in age, sex, or lifestyle habits were observed among PRS groups. The very high-risk group showed significantly higher follow-up fasting blood glucose levels (p = 0.001) and higher baseline and follow-up HbA1c levels (p = 0.0025 and p = 0.001, respectively), as well as a 4.5-fold increased risk of developing DM compared with other groups. Smoking significantly modified genetic risk, with smokers in the very high-risk group showing a 25% higher likelihood of developing DM. CDKAL1 and TCF7L2 variants were most prevalent in the moderate- and high-risk groups, while HHEX variants in the high-risk group showed the greatest susceptibility, particularly among current smokers. Overall, PRS-based genetic testing demonstrated potential clinical utility for stratifying individuals according to relative diabetes risk, highlighting a possible interaction between genetic susceptibility and lifestyle factors such as smoking

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genome-Wide Association StudyDiabetes Mellitus, Type 2HumansFemaleGenetic Risk ScorePolymorphism, Single NucleotideTranscription Factor 7-Like 2 ProteinMaleGenetic Predisposition to DiseaseMiddle AgedKCNQ1 Potassium ChannelGlycated HemoglobintRNA MethyltransferasesAdultBlood GlucoseTranscription FactorsGenetic TestingRisk FactorsRepublic of KoreaHomeodomain Proteins

Stichwörter der Autor:innen

CDKAL1HHEXKCNQ1Polygenic risk scoreReal-world evidenceTCF7L2Type 2 diabetes mellitusgenome-wide association study

Substanzen

Transcription Factor 7-Like 2 ProteinTCF7L2 protein, humanKCNQ1 Potassium ChannelGlycated HemoglobinKCNQ1 protein, humantRNA MethyltransferasesCDKAL1 protein, humanHHEX protein, humanBlood GlucoseTranscription Factors

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Dong-A University College of Medicine, Dong-A University Hospital, Busan 49201, Republic of Korea.
  • Theragen Health Co., Ltd., Seongnam 13488, Republic of Korea.
  • Department of Family Medicine, Dong-A University College of Medicine, Dong-A University Hospital, Busan 49201, Republic of Korea.

ORCID-Profile: In Hwa Jeong, Kyung-Won Hong, Ja-Eun Choi, Bo-Kyung Shine

Zitieren

APA

Jeong, I. H., Hong, K. W., Choi, J. E., & Shine, B. K. (2025). Real-World Utility of GWAS-Based Diabetes Mellitus Panel Testing. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27010275

Vancouver

Jeong IH, Hong KW, Choi JE, Shine BK. Real-World Utility of GWAS-Based Diabetes Mellitus Panel Testing. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms27010275

BibTeX
@article{Jeong2025,
  author = {Jeong, In Hwa and Hong, Kyung-Won and Choi, Ja-Eun and Shine, Bo-Kyung},
  title = {Real-World Utility of GWAS-Based Diabetes Mellitus Panel Testing},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms27010275}
}
Kostenlos starten →